Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Sharecast News) - The European Union expects to receive 107m doses of the coronavirus vaccine by the end of March, 30m of which will be of that developed by Anglo-Swedish firm AstraZeneca and the University of Oxford.
Read more
* European shares up 0.1%* Deliveroo flops on market debut* DAX hovers around 15,000 points* Eyes on Biden infrastructure planMarch 31 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your t...
Read moreBRUSSELS, March 31 (Reuters) - European Union states are expected to receive 107 million doses of COVID-19 vaccines by the end of March, an EU Commission spokeswoman said on Wednesday, hitting an earlier target but far below initial plans.Under c...
Read moreMarch 31 (Reuters) - The World Health Organization said on Wednesday it continues to monitor safety evidence reviews of AstraZeneca's COVID-19 vaccine but that the shot's benefit-risk profile "weighs heavily in favour of its use" amid reports of ...
Read more* European shares up 0.2%* Deliveroo flops on market debut* DAX hovers around 15,000 points* Eyes on Biden infrastructure planMarch 31 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your t...
Read morePARIS, March 31 (Reuters) - The Johnson & Johnson COVID-19 vaccine should arrive in France by the third or fourth week of April, French junior industry minister Agnes Pannier-Runacher told BFM TV on Wednesday. (Reporting by Benoit Van Overstraete...
Read morePARIS, March 31 (Reuters) - The French government will meet its target to have around 10 million people vaccinated against the COVID-19 virus by mid-April, French junior industry minister Agnes Pannier-Runacher told BFM TV on Wednesday. (Reportin...
Read more* European shares flat* Deliveroo flops on market debut* DAX hovers around 15,000 points* Eyes on Biden infrastructure planMarch 31 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thou...
Read more(Sharecast News) - The T-cells generated by the human body in response to the original strain of SARS-CoV-2 appear to also protect against the new strains of the virus that causes Covid-19, the results of a US laboratory study showed.
Read more* European shares edge up* Deliveroo flops on market debut* DAX above 15,000 points* Eyes on Biden infrastructure planMarch 31 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts ...
Read moreMarch 31 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comSO LONG Q1, U.S. LEADS GOING INTO Q2 (0702 GMT)The first quarter draws t...
Read moreA look at the day ahead from Dhara Ranasinghe.The first quarter draws to a close and what a quarter it's been: an 82 basis-point surge in U.S. Treasury yields on a stimulus boost the size of which few would have anticipated, a 25% oil price jump, ...
Read more(Writes through with ministry statement, background)MADRID, March 30 (Reuters) - Spain confirmed on Tuesday it would use AstraZeneca Plc's COVID-19 vaccine for people aged 55-65, and said it could give Johnson & Johnson's version of the jab to old...
Read moreBERLIN, March 30 (Reuters) - German Chancellor Angela Merkel is open to being vaccinated with Astrazeneca's COVID-19 jab, she told a news conference on Tuesday."I have said when it is my turn, I will get vaccinated, also with AstraZeneca," the 66-...
Read moreBERLIN, March 30 (Reuters) - Germany will restrict the use of AstraZeneca's COVID-19 vaccine to people aged 60 and over and high-priority groups, Chancellor Angela Merkel said on Tuesday.The move, agreed with the 16 federal states, follows the re...
Read more
Last checked at